Woodmont Investment Counsel LLC Sells 455 Shares of MetLife, Inc. $MET

Woodmont Investment Counsel LLC lowered its position in MetLife, Inc. (NYSE:MET) by 4.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 8,811 shares of the financial services provider’s stock after selling 455 shares during the period. Woodmont Investment Counsel LLC’s holdings in MetLife were worth $709,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of MET. Brighton Jones LLC increased its stake in MetLife by 9.0% during the 4th quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock valued at $347,000 after purchasing an additional 351 shares in the last quarter. UMB Bank n.a. raised its holdings in shares of MetLife by 8.9% in the 1st quarter. UMB Bank n.a. now owns 7,586 shares of the financial services provider’s stock worth $609,000 after acquiring an additional 619 shares during the last quarter. Park Avenue Securities LLC boosted its stake in MetLife by 5.7% during the 1st quarter. Park Avenue Securities LLC now owns 39,409 shares of the financial services provider’s stock valued at $3,164,000 after purchasing an additional 2,119 shares during the last quarter. Farther Finance Advisors LLC increased its holdings in MetLife by 36.9% during the 1st quarter. Farther Finance Advisors LLC now owns 15,330 shares of the financial services provider’s stock worth $1,244,000 after purchasing an additional 4,133 shares in the last quarter. Finally, Pallas Capital Advisors LLC purchased a new stake in shares of MetLife in the first quarter worth approximately $474,000. 94.99% of the stock is currently owned by institutional investors.

MetLife Stock Down 0.0%

MET opened at $82.34 on Tuesday. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $89.05. The company has a market cap of $54.76 billion, a PE ratio of 13.96, a price-to-earnings-growth ratio of 0.74 and a beta of 0.86. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.57. The company has a 50 day moving average of $79.20 and a 200 day moving average of $78.14.

MetLife (NYSE:MET) last posted its quarterly earnings results on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing analysts’ consensus estimates of $2.32 by ($0.30). MetLife had a return on equity of 19.88% and a net margin of 5.83%.The company had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $18.58 billion. During the same period in the previous year, the business earned $2.28 earnings per share. MetLife’s revenue was down 2.7% on a year-over-year basis. On average, sell-side analysts expect that MetLife, Inc. will post 9.65 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Piper Sandler downgraded MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 price target for the company. in a report on Friday, September 19th. Jefferies Financial Group upped their target price on shares of MetLife from $100.00 to $103.00 and gave the stock a “buy” rating in a research note on Monday, August 11th. Wells Fargo & Company reiterated an “overweight” rating and issued a $97.00 price objective (up previously from $94.00) on shares of MetLife in a research note on Thursday, July 10th. Keefe, Bruyette & Woods cut their target price on MetLife from $94.00 to $92.00 and set an “outperform” rating on the stock in a research note on Monday, August 11th. Finally, JPMorgan Chase & Co. increased their price target on MetLife from $86.00 to $95.00 and gave the company an “overweight” rating in a research report on Tuesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $94.64.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.